|
(2,3,5,6-tetrachloro-4-nitrophenyl)methyl radical
|
C520705 |
|
|
crispatenine
|
C520706 |
|
|
G protein-coupled receptor GPR26, mouse
|
C520707 |
|
|
2-(2'-imidazolium)phenyl phosphate
|
C520708 |
|
|
KS 502
|
C060469 |
|
|
cowaniin
|
C520700 |
|
|
bostrycoidin
|
C060461 |
|
|
7-hydroxyethyl-1-oxacephem
|
C060462 |
|
|
spectrin Tunis
|
C060463 |
|
|
sclareol glycol
|
C060464 |
|
|
omega-agatoxin I
|
C060465 |
|
|
4-O-acetyl-1,5-anhydro-2,3,6-trideoxy-3-trifluoroacetamidohex-1-enitol
|
C060466 |
|
|
HIV pol protein p65
|
C060467 |
|
|
KS 501
|
C060468 |
|
|
G protein-coupled receptor GPR78, human
|
C520709 |
|
|
lavanducyanin
|
C060460 |
|
|
Personnel, Hospital
|
D010564 |
[The individuals employed by the hospital.
] |
|
Persuasive Communication
|
D010565 |
[A mode of communication concerned with inducing or urging the adoption of certain beliefs, theories, or lines of action by others.
] |
|
Virulence Factors, Bordetella
|
D010566 |
[A set of BACTERIAL ADHESINS and TOXINS, BIOLOGICAL produced by BORDETELLA organisms that determine the pathogenesis of BORDETELLA INFECTIONS, such as WHOOPING COUGH. They include filamentous hemagglutinin; FIMBRIAE PROTEINS; pertactin; PERTUSSIS TOXIN; ADENYLATE CYCLASE TOXIN; dermonecrotic toxin; tracheal cytotoxin; Bordetella LIPOPOLYSACCHARIDES; and tracheal colonization factor.
] |
|
Pertussis Vaccine
|
D010567 |
[A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed)
] |
